biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Post by unclepiemanon Dec 13, 2016 11:44am

195 Views

Post# 25592036

whats next...

So i've been waiting for about a good 4 years now and I really thought this was it... it was time for us to see a rise in the price.

I've surprized that the price hit $1.03 today but i'm not surprized as to why, management really sucks.

with 40 companies interested in doing testing/business with us, im going to wait until 2017 to see how things go.

GLTA and happy 2016

Bullboard Posts

The top 10 Canadian medical stocks